<DOC>
	<DOCNO>NCT01233648</DOCNO>
	<brief_summary>This study do find control rate control rhythm well heart failure patient also AF . Patients AF receive CRT-D device AV node ablation part clinical care follow one year . One group heart rate control ICD AVN ablation alone second group treat ICD , AVN ablation standard medical therapy restore heart 's normal rhythm . The study doctor compare information collect subject study see treat rate treat rhythm well patient heart failure AF , result good quality life .</brief_summary>
	<brief_title>Resync-AF ( Rate v Rhythm Control AF Patients With CRT-D )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Having persistent AF , define AF self terminate least 24 consecutive hour . In AF upon entry operate room CRTD implantation AV node ablation . Being stable dosage ACE inhibitor ARB least 1 month precede implant Being Betablocker least 3 month precede implant stable dosage within 1 month implant Not take able take type I/III antiarrhythmic medication . Taking Coumadin maintain INR 2 3 . A Class I IIa ICD indication NYHA Class III/IV within 1 month baseline Intrinsic QRS duration ≥ 130 m within 1 month prior baseline Left ventricular ejection fraction ≤ 35 % ( method per physician discretion ) within 1 month prior baseline Left ventricular end diastolic dimension ( LVEDD ) ≥ 55 mm ( method per physician discretion ) within 1 month prior baseline Willing provide write informed consent Are expect survive 6 month study participation Able tolerate urgent thoracotomy Able tolerate &lt; 1 mg dexamethasone sodium phosphate ( steroid ) Having selfterminating interminable AF Having unstable angina , experience acute myocardial infarction ( MI ) receive coronary artery revascularization ( CABG ) coronary angioplasty ( PTCA ) within past 1 month Postheart transplant ( patient heart transplant list first time exclude ) Having mechanical right heart valve Having exist CRT atrial therapy device ( ) Being enrol concurrent drug and/or device study would confound result trial Having primary valvular disease indicate valve repair replacement Having previous AV node ablation Being Type I Type III antiarrhythmic medication treatment ventricular tachyarrhythmias Women pregnant child bear potential reliable form birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>heart failure</keyword>
	<keyword>CRT-D</keyword>
</DOC>